Evidence that nitric oxide can act centrally to stimulate vasopressin release

Neuroendocrinology

Volumn 57, Issue 5, 1993, Pages 955-959

  Ota, Masahiro ^a   Crofton, Joan T ^a   Festavan, Gregory T ^a   Share, Leonard ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Blood pressure; L Arginine; Nitric oxide; S Nitroso N acetylpenicillamine; Vasopressin

Indexed keywords

ARGININE; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; VASOPRESSIN;

ANIMAL EXPERIMENT; ARTICLE; BIOSYNTHESIS; BLOOD PRESSURE; BRAIN NERVE CELL; CONTROLLED STUDY; DOSE RESPONSE; HYPOTHALAMUS; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE RELAXATION; VASCULAR SMOOTH MUSCLE; VASOPRESSIN BLOOD LEVEL; VASOPRESSIN RELEASE;

ANIMAL; ARGININE; BLOOD PRESSURE; BRAIN; INJECTIONS, INTRAVENTRICULAR; MALE; NITRIC OXIDE; PENICILLAMINE; RATS; RATS, SPRAGUE-DAWLEY; S-NITROSO-N-ACETYLPENICILLAMINE; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; VASOPRESSINS;

EID: 0027275342     PISSN: 00283835     EISSN: 14230194     Source Type: Journal    
DOI: 10.1159/000126459     Document Type: Article

References (16)

1. Furchgott RF, Zawadzki JV: The obligatory role of endothelial cells in [he relaxation of arterial smooth muscle by acetylcholine. Nature 1980;327:373-376.
2. Palmer RMJ. Ashton DS. Moncada S: Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988:333:664-666.
3. Knowles RG. Palacios M. Palmer RMJ. Moncada S: Formation of nitric oxide from L-ar-ginine in the central nervous system: A transduction mechanism for stimulation of the soluble guanylate cyclase. Proc Natl Acad Sci USA 1989;86:5159-5162.
4. Schmilt HHHW. Wilke P. Evers B. Bohme E: Enzymatic formation of nitric oxide from L-arginine in bovine brain cytosol. Biochem Biophys Res Commun 1989;165:284-291.
5. Bredt DS. Snyder SH: Isolation of nitric oxide oxide synthetase, a calmodulin-requiring enzyme. Proc Natl Acad Sci USA 1990;87: 682-685.
6. Ross CA. Bredt D. Snyder SH: Messenger molecules in the cerebellum. TINS 1990;13: 216-222.
7. Garthwaite J, Charles SL, Williams RC: En-dothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature 1988:336:385-388.
8. Bredt DS. Snyder SH: Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc Natl Acad Sci USA 1989:86:9093.
9. Moncada S. Palmer RMJ. Higgs EA: Nitric oxide: Pathophysiology and pharmacology. Pharmacol Rev 1991:43:109-142.
10. Forstermann U, Gorsky LD, Pollock JS, Schmidt HHHW, Heller M, Murad F: Regional distribution of EDRF/NO-synthesiz-ing enzymc(S) in rat brain. Biochem Biophys Res Commun 1990;168:727-732.
11. Field L: An unusually stable thionitrite from N-acetyl-D. L-penicillamine; X-ray crystal and molecular structure of 2-(acetylamino)-2-car-boxy-l, l-dimethylethyl thionitrite. J CS ChemComm 1978:249-250.
12. Crofton JT. Share L. Wang BC. Shade RE: Pressor responsiveness to vasopressin in the rat with DOC-salt hypertension. Hypertension 1980;2:424-431.
13. Eriksson S, Appelgren B. Rundgren M, An-dersson B: Vasopressin release in response to intracerebroventricular L-alanine and L-ar-ginine. and its dependence upon CSF NaCI concentration. Acta Physiol Scand 1982;116; 75-81.
14. Schuman EM, Madison DV: A requirement for the intracellular messenger nitric oxide in long-term potentiation. Science 1991;254: 1503-1506.
15. Bic P: Quantitative aspects of renal actions of vasopressin. Acta Physiol Scand 1990:139: 28-32.
16. Crofton JT. Share L. Brooks DP: Pressor responsiveness to and secretion of vasopressin during the estrous cycle. Am J Physiol 1988; 255:R1041-R1048.